Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ENPP1 | P22413 | 2/20 | 0.43 |
| ▸ | ENPP3 | O14638 | 1/20 | 0.43 |
| ▸ | S1PR1 | P21453 | 1/20 | 0.40 |
| ▸ | S1PR3 | Q99500 | 1/20 | 0.40 |
| ▸ | PPARG | P37231 | 1/20 | 0.40 |
| ▸ | PPARA | Q07869 | 1/20 | 0.40 |
| ▸ | ALDH1A1 | P00352 | 5/20 | 0.40 |
| ▸ | MAPT | P10636 | 5/20 | 0.40 |
| ▸ | HPGD | P15428 | 5/20 | 0.40 |
| ▸ | KDM4E | B2RXH2 | 4/20 | 0.40 |
| ▸ | TDP1 | Q9NUW8 | 2/20 | 0.40 |
| ▸ | L3MBTL1 | Q9Y468 | 2/20 | 0.40 |
| ▸ | TP53 | P04637 | 1/20 | 0.40 |
| ▸ | TSHR | P16473 | 1/20 | 0.40 |
| ▸ | NFKB1 | P19838 | 1/20 | 0.40 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.40 |
| ▸ | NFKB2 | Q00653 | 1/20 | 0.40 |
| ▸ | RELA | Q04206 | 1/20 | 0.40 |
| ▸ | ATM | Q13315 | 1/20 | 0.40 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.40 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL19483244 | 0.95 | MEN1 (0.40) | ENPP1ENPP3S1PR1S1PR3PPARG | |
| SCHEMBL17725012 | 0.93 | ENPP1 (0.38) | ENPP1ENPP3S1PR1S1PR3PPARG | |
| SCHEMBL17725653 | 0.92 | MEN1 (0.42) | ENPP1ENPP3PPARGPPARAALDH1A1 | |
| SCHEMBL17725014 | 0.92 | MEN1 (0.42) | ENPP1ENPP3PPARGPPARAALDH1A1 | |
| SCHEMBL17725646 | 0.89 | SMN1; SMN2 (0.44) | ENPP1ENPP3S1PR1S1PR3PPARG | |
| SCHEMBL19313853 | 0.84 | PPARG (0.47) | ENPP1ENPP3PPARGPPARAALDH1A1 | |
| SCHEMBL17725005 | 0.83 | MEN1 (0.54) | ALDH1A1MAPTHPGDKDM4ETDP1 | |
| SCHEMBL17725644 | 0.83 | MEN1 (0.54) | ALDH1A1MAPTHPGDKDM4ETDP1 | |
| SCHEMBL10051315 | 0.83 | ALDH1A1 (0.50) | ENPP1ENPP3ALDH1A1MAPTHPGD | |
| SCHEMBL18732401 | 0.83 | MAPT (0.53) | ENPP1ENPP3ALDH1A1MAPTHPGD |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 11 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-3389108-B1 | ORGANIC LIGHT-EMITTING ELEMENT | LG CHEMICAL LTD (KR) | 2023-09-13 | — | — | EP | disclosed |
| US-11723268-B2 | Organic light-emitting element | LG CHEM, LTD. | 2023-08-08 | — | — | US | disclosed |
| US-11723268-B2 | Organic light-emitting element | LG CHEM, LTD. | 2023-08-08 | — | — | US | disclosed |
| EP-3388496-B1 | ORGANIC LIGHT-EMITTING ELEMENT COMPRISING DIBENZOFURAN-ANTHRACENE DERIVATIVE IN LIGHT EMITTING LAYER AND DIPHENYLMETHYL DERIVATIVE IN ELECTRON INJECTION LAYER | LG CHEMICAL LTD (KR) | 2021-02-24 | — | — | EP | disclosed |
| US-20200136053-A1 | ORGANIC LIGHT-EMITTING ELEMENT | LG CHEM, LTD. (KR) | 2020-04-30 | — | — | US | disclosed |
| EP-3214084-B1 | CYCLIC COMPOUND AND ORGANIC LIGHT-EMITTING ELEMENT COMPRISING SAME | LG CHEMICAL LTD (KR) | 2020-02-19 | — | — | EP | disclosed |
| US-10431748-B2 | Cyclic compound and organic light-emitting element comprising same | LG CHEM, LTD. (KR) | 2019-10-01 | — | — | US | disclosed |
| US-20190019961-A1 | ORGANIC LIGHT-EMITTING ELEMENT | LG CHEM, LTD. (KR) | 2019-01-17 | — | — | US | disclosed |
| US-20170301866-A1 | CYCLIC COMPOUND AND ORGANIC LIGHT-EMITTING ELEMENT COMPRISING SAME | LG CHEM, LTD. (KR) | 2017-10-19 | — | — | US | disclosed |
| US-20170301866-A1 | CYCLIC COMPOUND AND ORGANIC LIGHT-EMITTING ELEMENT COMPRISING SAME | LG CHEM, LTD. (KR) | 2017-10-19 | — | — | US | disclosed |
| EP-3214084-A2 | CYCLIC COMPOUND AND ORGANIC LIGHT-EMITTING ELEMENT COMPRISING SAME | LG Chem, Ltd. (KR) | 2017-09-06 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20170301866-A1 | CYCLIC COMPOUND AND ORGANIC LIGHT-EMITTING ELEMENT COMPRISING SAME | CRY1, CRY2, PER2 | ENPP1 1521/4885ENPP3 1858/4885S1PR1 4739/4885 |
| US-11723268-B2 | Organic light-emitting element | CRY2, NR2E3, CRY1 | ENPP1 1656/4885ENPP3 1560/4885S1PR1 4864/4885 |
| US-10431748-B2 | Cyclic compound and organic light-emitting element comprising same | CRY1, CRY2, PER2 | ENPP1 1521/4885ENPP3 1858/4885S1PR1 4739/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.